The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.
- Past awards
- 26
- 26 new
- Median first-year cost
- $42,682
- $1,080,498 in all
- Institutions
- 26
- 26 contact PIs
Awards by fiscal year
0
0
0
0
0
0
26
0
0
0
0
0
0
14151617181920212223242526
Fiscal years 2014 to 2026.
Most frequent institutions
- BAYLOR COLLEGE OF MEDICINE1
- COLUMBIA UNIV NEW YORK MORNINGSIDE1
- EMORY UNIVERSITY1
- HARVARD UNIVERSITY1
- JOHNS HOPKINS UNIVERSITY1
and 21 other institutions
Most frequent study sections
- Special Emphasis Panel (ZCA1 SRB-H (M1))26
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| FY2020 | Improving Family Cancer History Collection using Social Network, Human Centered Design, and Implementation Science Approaches1K00CA253576-01 | Allen, Caitlin Gloeckner | EMORY UNIVERSITY, GA | First-year cost $47,020 | Study section ZCA1 |
| FY2020 | Dissecting the molecular mechanisms of PRC2 dysregulation in cancer1F99CA253687-01 | Patriotis, Agata Ewa | ROCKEFELLER UNIVERSITY, NY | First-year cost $47,020 | Study section ZCA1 |
| FY2020 | Development of senolytic CAR T cells as new therapeutic agents1F99CA253706-01 | Amor Vegas, Corina | SLOAN-KETTERING INST CAN RESEARCH, NY | First-year cost $47,020 | Study section ZCA1 |
| FY2020 | Targeting Oncogenic Drivers in Cancer1F99CA253731-01 | Boudreau, Matthew W | UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL | First-year cost $47,020 | Study section ZCA1 |
| FY2020 | A Multi-omics Approach to Examine Symptoms and Medication Adherence in Women with Breast Cancer1F99CA253771-01 | McCall, Maura Kindelan | UNIVERSITY OF PITTSBURGH AT PITTSBURGH, PA | First-year cost $47,020 | Study section ZCA1 |
| FY2020 | Disruptive methods for increased chemotherapy distribution into preclinical brain metastases of breast cancer leading to improved tumor kill and prolonged survival.1F99CA253768-01 | Sprowls, Samuel Adam Tyler | WEST VIRGINIA UNIVERSITY, WV | First-year cost $47,020 | Study section ZCA1 |
| FY2020 | Engineered Fibroblasts as Cell Therapy to Treat Colorectal Cancer via Tumor Stroma Stabilization1F99CA253759-01 | Jung, Wei-Hung | JOHNS HOPKINS UNIVERSITY, MD | First-year cost $47,020 | Study section ZCA1 |
| FY2020 | Improving the Efficacy of Allogeneic Cell Therapies of Cancer1F99CA253757-01 | Mo, Feiyan | BAYLOR COLLEGE OF MEDICINE, TX | First-year cost $47,020 | Study section ZCA1 |
| FY2020 | Addressing Obesity to Reduce Cancer Risk and Health Disparities in Underserved Populations1F99CA253745-01 | Zhang, Xiaochen | OHIO STATE UNIVERSITY, OH | First-year cost $47,020 | Study section ZCA1 |
| FY2020 | Assessing Helicobacter pylori and Diet to Develop Cancer Interventions in American Indian Communities in the Southwest1F99CA253685-01 | Pete, Dornell | UNIVERSITY OF WASHINGTON, WA | First-year cost $46,987 | Study section ZCA1 |
| FY2020 | Characterizing Chromatin Remodeling Mechanisms of Chemo-Sensitivity and Resistance in Pediatric Solid Tumors1F99CA253749-01 | Chasse, Maggie | VAN ANDEL INSTITUTE GRADUATE SCHOOL, MI | First-year cost $46,020 | Study section ZCA1 |
| FY2020 | Engineering tumor-targeting bacteria to sense and deliver therapeutics1F99CA253756-01 | Harimoto, Tetsuhiro | COLUMBIA UNIV NEW YORK MORNINGSIDE, NY | First-year cost $45,520 | Study section ZCA1 |
| FY2020 | Using chemoproteomic approaches to expand upon induced-proximity modalities for cancer therapy1F99CA253717-01 | Spradlin, Jessica Nichole | UNIVERSITY OF CALIFORNIA BERKELEY, CA | First-year cost $43,124 | Study section ZCA1 |
| FY2020 | Understanding Physical Activity and Quality of Life in Black Breast Cancer Survivors1F99CA253762-01 | Burse, Natasha Renee | PENNSYLVANIA STATE UNIV HERSHEY MED CTR, PA | First-year cost $42,240 | Study section ZCA1 |
| FY2020 | Tumor and Immune Cell Dynamics during Immunotherapy and Cancer Progression1F99CA253729-01 | Yost, Kathryn Elizabeth | STANFORD UNIVERSITY, CA | First-year cost $39,206 | Study section ZCA1 |
| FY2020 | Structure-Guided Mechanistic Studies of Dot1L in Mixed Lineage Leukemia1F99CA253730-01 | Spangler, Catherine Jeanette | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | First-year cost $38,344 | Study section ZCA1 |
| FY2020 | Single cell analysis and live imaging of tissue stem cells and cancer initiating cells1F99CA253738-01 | Zhang, Chi | UNIVERSITY OF COLORADO, CO | First-year cost $38,116 | Study section ZCA1 |
| FY2020 | Deciphering molecular mechanisms underlying cellular plasticity and metastasis1F99CA253718-01 | Baker, Emily Arner | UT SOUTHWESTERN MEDICAL CENTER, TX | First-year cost $37,716 | Study section ZCA1 |
| FY2020 | EMT drives targetable metabolic dependencies in breast cancer1F99CA253742-01 | O'Neill, Kathleen | UNIVERSITY OF COLORADO DENVER, CO | First-year cost $37,655 | Study section ZCA1 |
| FY2020 | Leveraging Implementation Science to Promote Behavior Change and Reduce Cancer Health Disparities among American Indian and Alaska Native Older Adults1F99CA253761-01 | Pedersen, Maja | UNIVERSITY OF MONTANA, MT | First-year cost $37,543 | Study section ZCA1 |
| FY2020 | Contextualizing Chaotic Metabolic Networks and Their Regulation1F99CA253744-01 | Berg, Jordan Alexander | UNIVERSITY OF UTAH, UT | First-year cost $36,742 | Study section ZCA1 |
| FY2020 | Targeting Endogenous Retrovirus Regulation for Augmenting Cancer Immunotherapy1F99CA253767-01 | McGeary, Meaghan K. | YALE UNIVERSITY, CT | First-year cost $36,062 | Study section ZCA1 |
| FY2020 | Long non-coding RNAs as novel therapeutic targets in gliomas treatment1F99CA253732-01 | Przanowska, Roza Kamila | UNIVERSITY OF VIRGINIA, VA | First-year cost $35,633 | Study section ZCA1 |
| FY2020 | Expanding pharmacological modalities for targeted cancer therapy1F99CA253754-01 | Yoon, Hojong | HARVARD UNIVERSITY, MA | First-year cost $32,983 | Study section ZCA1 |
| FY2020 | Lipid-based Cancer Therapeutics1F99CA253758-01 | Morstein, Johannes | NEW YORK UNIVERSITY, NY | First-year cost $32,407 | Study section ZCA1 |
| FY2020 | Translation of small open reading frames in 3'UTR enhances translation of canonical open reading frames1F99CA253719-01 | Wu, Qiushuang | STOWERS INSTITUTE FOR MEDICAL RESEARCH, MO | First-year cost $31,020 | Study section ZCA1 |
Newest fiscal year first, then first-year cost.
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-20-0.3.9. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.